Regenerative medicine aims to repair or replace damaged tissue, rather than simply manage the symptoms. But across the clinic websites we reviewed for these guides, the term works as a marketing label, borrowing the credibility of proven transplant medicine to promote an unproven knee injection. The research is real; the label hides which of the two you are being offered.
What the Term Covers
Regenerative medicine spans four groups of treatment that share a goal and almost nothing else. Sort them by approval status and the label starts to mean something.
- Cell therapy. Transplanting living cells, from bone marrow transplants for leukemia through to the stem cell injections clinics sell for joints.
- Gene therapy. Altering or replacing faulty genes. Several products have full FDA approval for inherited conditions.
- Tissue engineering. Growing replacement tissue, such as the lab-grown skin grafts used in burn units.
- Blood-derived injections. Platelet-rich plasma and exosome products, which use components of blood or cell secretions rather than whole cells.
The first three carry approved products treating real diseases today. The fourth, along with most orthopedic uses of the first, does not.
What Has FDA Approval
A small number of regenerative treatments have cleared FDA approval. Know which ones, and a clinic cannot borrow that approval for something else. Hematopoietic stem cell transplants for blood cancers and some immune disorders are the oldest, with decades of outcome data behind them. Several gene therapies have won FDA approval for inherited retinal disease and spinal muscular atrophy. Cord blood products are approved for a defined list of blood disorders.
Nothing on that list treats a knee. The FDA has approved no stem cell product for osteoarthritis, back pain, tendon injury, or cosmetic use. It has issued a consumer alert after patients were harmed, including three women who lost vision following an eye injection at a Florida clinic. Our FDA status guide sets out how the agency classifies each product type.
How Clinics Use the Word
A clinic that calls itself a regenerative medicine center is describing a category. No credential attaches to the phrase. No licensing body certifies it either, so a practice can use the label accurately while offering only the unapproved treatments in the list above.
Readers get caught by clinic sites that open with transplant medicine and gene therapy, then sell a knee injection on the next page. All three belong to regenerative medicine, but only the gene therapy and the transplant carry an FDA approval. The knee injection on the price page does not. Ask which specific product you are buying and what its regulatory status is, rather than accepting the field’s name as an answer.
Proven versus Sold, Side by Side
| Treatment | Regulatory status | What the evidence supports |
|---|---|---|
| Bone marrow or cord blood transplant | FDA approved | Established for blood cancers and defined blood disorders |
| Approved gene therapies | FDA approved | Specific inherited conditions, on trial data |
| Ryoncil (remestemcel-L) | FDA approved, 2024 | Steroid-refractory acute graft-versus-host disease in children |
| Lab-grown skin grafts | FDA approved | Burn and wound coverage |
| Stem cell injection for a joint | Not approved | Low to very low certainty for knee osteoarthritis |
| Platelet-rich plasma for a joint | Not approved as a drug | Mixed, better studied than stem cells |
| Exosome products | Not approved | No controlled human evidence for orthopedic use |
The approvals cluster around treatments that replace a failing biological system. Nothing injected into a painful joint replaces a system.
The One Approval Clinics Lean On
Ryoncil is the approval a clinic can cite most persuasively, so it is worth understanding before you hear it. It is a mesenchymal stromal cell therapy, approved in 2024 for steroid-refractory acute graft-versus-host disease in children after a transplant. Most joint clinics inject mesenchymal cells too, so the overlap in cell type is real.
The overlap ends there. Ryoncil is a manufactured product with a defined dose, a defined indication, and trial data the FDA reviewed. A same-day fat or marrow preparation is an unmeasured concentrate of your own tissue, given for a condition Ryoncil was never tested on. A product that shares a cell family with an approved drug gains nothing from the resemblance. A supplement in the same ingredient class as a prescription drug is still a supplement.
The claim arrives in three steps. A clinic tells you the FDA has approved a mesenchymal stem cell therapy. That statement is true. The clinic then lets you carry the approval across to the injection it sells, which the FDA has never reviewed. If a clinic raises Ryoncil, ask whether the product it plans to inject into you is Ryoncil. It will not be. Our FDA status guide lists every approved cell product alongside the uses clinics advertise.
Why the Orthopedic Evidence Stays Thin
Joint injections ask cells to survive and act in a hostile, low-oxygen environment, and many injected cells die or clear within days to weeks. A Cochrane review of stem cell injections for knee osteoarthritis pooled the randomized trials and rated the certainty of the evidence low to very low, with small studies and short follow-up. For how long any benefit from a joint injection typically lasts, see our dedicated breakdown. Platelet-rich plasma has a larger trial base and still produces mixed results, as our comparison guide covers.
The gap is not evidence the idea is wrong. It is evidence the idea is unfinished, and a single joint injection runs $3,000 to $8,000 whether or not the idea pans out.
Prolotherapy and the Rest of the Label
Prolotherapy sits under the same banner and is worth separating out, because it is not a cell treatment at all. A clinician injects an irritant solution, usually concentrated dextrose, to provoke a local healing response in a ligament or tendon. No stem cells, no platelets, no biological product.
It is grouped with regenerative medicine on marketing pages because the goal matches. The evidence is separate and generally weaker than for platelet-rich plasma, and it is cheaper by an order of magnitude, often a few hundred dollars per session rather than thousands. A clinic that quotes stem cell prices for what is in practice a dextrose injection has mispriced the treatment, so ask which solution is going into the syringe.
Who This Is Not For
If you are researching a stem cell transplant for leukemia or a lymphoma, this page is the wrong one and the concern behind it does not apply to you. That treatment is approved, insurer-covered, and delivered through oncology, and our caution here is about the orthopedic and cosmetic market. If you are weighing a joint injection, our cost guide and worth-it analysis are the more useful next reads.
What Would Change This Answer
An orthopedic cell product clearing an FDA trial would move joint injections onto the approved side of the table above, and several candidates are in trials now. A large blinded study showing durable benefit past the placebo response would do the same. Either would make the label mean something specific for joints, which today it does not.
How to Read the Term from Here
Treat regenerative medicine as the name of a research field. Then ask any clinic using it which product it is injecting, and whether the FDA has approved that product for your condition. Check the answer against the FDA’s approved cellular and gene therapy products list. Price whatever they say against physical therapy and a cortisone injection using our cost breakdown before you commit.
Frequently asked questions
What are examples of regenerative medicine?
Approved examples include bone marrow and cord blood transplants for blood cancers, several gene therapies, and lab-grown skin grafts for burns. Unapproved but widely sold examples include stem cell injections for joints, platelet-rich plasma, exosome products, and prolotherapy. The label covers both groups, which is why it tells you so little on its own.
Is regenerative medicine legitimate?
As a field of research it is legitimate and long established, with FDA-approved products treating blood cancers and some inherited diseases. As a clinic marketing term it is often applied to joint and cosmetic treatments that have no approval and thin evidence. The word describes an ambition. It sets no standard of proof.
Is regenerative medicine covered by insurance?
Approved uses such as a stem cell transplant for leukemia are covered. The orthopedic and cosmetic treatments sold under the same label are almost never covered, because insurers classify them as investigational. Expect to pay out of pocket for anything a clinic advertises as regenerative for a joint.
What is the difference between regenerative medicine and stem cell therapy?
Regenerative medicine is the broader field, covering gene therapy, tissue engineering, platelet-rich plasma, and stem cell treatments. Stem cell therapy is one branch of it. A clinic using the wider term for a single injection is naming the category it wants to be associated with. It is not describing the treatment you are buying.
What is the biggest problem with regenerative medicine?
Commercial marketing for regenerative medicine routinely outpaces scientific evidence, so patients pay out of pocket for procedures that offer no guarantee of benefit. Beyond the financial loss, unregulated injected biologics carry real physical risks, including infection and unpredictable immune reactions. A Food and Drug Administration (FDA) consumer alert documented this danger after three women lost their vision from stem cell eye injections.
What is tissue engineering, and how is it different from a stem cell injection?
Tissue engineering builds replacement tissue using biological scaffolds, such as lab-grown skin grafts for severe burns, whereas a stem cell injection delivers isolated cells directly into an injured joint or tissue bed. Medical specialties including orthopedics, podiatry, and dentistry are actively researching engineered scaffolds to guide tissue repair. In laboratory settings, zebrafish serve as a standard model organism because they naturally regrow fin and heart tissue after injury, a regenerative capacity that human tissue lacks. That shared developmental-biology research does not confer regulatory approval, and early laboratory work does not give an unapproved clinical injection the proven status of an established tissue graft.
What does a clinic's 'regenerative medicine certification' or 'academy' credential actually mean?
A certificate from a private academy or commercial training program is issued by an independent organization. Neither the Food and Drug Administration (FDA) nor any state medical board issues, verifies, or regulates these private credentials. The certificates confirm that clinic staff completed an instructional seminar, but they do not establish that a treatment is proven, safe, or federally cleared. Patients evaluating an unproven therapy should vet the clinic by verifying federal regulatory filings rather than relying on decorative credentials.
Is regenerative medicine worth it?
Whether regenerative medicine is worth the out-of-pocket cost depends on the exact treatment being sold. The broader field encompasses established, life-saving therapies like bone marrow transplants for leukemia alongside unproven orthopedic injections that cost $3,000 to $8,000 per joint. Patients should verify a procedure's regulatory status and compare the total treatment cost against better-studied medical alternatives before scheduling an appointment. A dedicated cost-versus-evidence assessment can clarify whether the limited odds of improvement justify paying for an unapproved injection.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.